Category: studies

COVID Study 2023

BETTER SPERM QUALITY
AFTER COVID INFECTION

»Significant increase in the percentage of normal semen analysis results, in progressive motility and vitality«

COVID STUDY 2023

PROFERTIL® improves sperm quality
after a symptomatic COVID infection.

Number of patients:
n = 40
(PROFERTIL®-group: n = 30;
Control group: n = 10)

Publication:
A prospective study, Arch Ital Urol
Androl. 2023 Mar 13;95(1).

Proven effect:
  • significant increase in the percentage of normal semen analysis results after 3-month of PROFERTIL® regimen
  • significant increase in the progressive motility as well as in the vitality after 3-month of PROFERTIL® regimen

Aschauer J. et al., Recovery of sperm quality after COVID-19 disease in male adults under the influence of a micronutrient combination: A prospective study, Arch Ital Urol Androl. 2023 Mar 13;95(1).

PREGNANCY RATE Ø 26-41%

DNA Study 2021

REDUCES
DNA FRAGMENTATION

»Significant reduction of DNA fragmentation in sperm«

DNA STUDY 2021

Reduction of sperm DNA fragmentation (DFI in %) after 3 months of PROFERTIL® regimen

Number of patients:
n = 339
(PROFERTIL®-group: n = 162;
Control group: n = 177)

The unique, patented composition of PROFERTIL®:
  • Significantly decreases sperm DNA fragmentation compared to the control group (lifestyle change only).
  • Pregnancy rate 41.3% in PROFERTIL® Subgroup DFI > 15% vs. 22.9% in control group
  • Pregnancy rate 27.8% in PROFERTIL® group vs. 15.3% in control group (total study population)

DNA-Study 2021; The effect of micronutrient supplementation on spermatozoa DNA integrity in subfertile men and subsequent pregnancy rate; Lipovac M. et al.; published in Gynecological Endocrinology 2021 Jun; 37(6); patients (n = 339): PROFERTIL® group: n=162, control group n=177. 

PREGNANCY RATE Ø 26-41%